CT/NG Testing Market worth $2.7 billion by 2028
CT/NG testing market refers to the market for testing Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections. CT and NG are two of the most common sexually transmitted infections (STIs) globally. Testing for these infections is crucial because they can often be asymptomatic, leading to their spread unknowingly and potentially causing serious health issues if left untreated....
0 Comments 0 Shares 638 Views 0 Reviews